Hepatic Impairment

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS withdrawal · 2021-06-10
Clinical Trial Update: Pharmacokinetics of Single-dose Dolutegravir in HIV-seronegative Subjects With Severe Hepatic Impairment Compared to Matched Controls. [Phase 4]
A Phase 4 pharmacokinetic trial evaluating single-dose dolutegravir in HIV-seronegative subjects with severe hepatic impairment compared to …